BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 29511171)

  • 1. Disease-associated missense mutations in GluN2B subunit alter NMDA receptor ligand binding and ion channel properties.
    Fedele L; Newcombe J; Topf M; Gibb A; Harvey RJ; Smart TG
    Nat Commun; 2018 Mar; 9(1):957. PubMed ID: 29511171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of GluN2A and GluN2B gain-of-function epilepsy mutations on synaptic currents mediated by diheteromeric and triheteromeric NMDA receptors.
    Chen X; Keramidas A; Harvey RJ; Lynch JW
    Neurobiol Dis; 2020 Jul; 140():104850. PubMed ID: 32247039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GRIN2B gain of function mutations are sensitive to radiprodil, a negative allosteric modulator of GluN2B-containing NMDA receptors.
    Mullier B; Wolff C; Sands ZA; Ghisdal P; Muglia P; Kaminski RM; André VM
    Neuropharmacology; 2017 Sep; 123():322-331. PubMed ID: 28533163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Mechanism of Disease-Associated Mutations in the Pre-M1 Helix of NMDA Receptors and Potential Rescue Pharmacology.
    Ogden KK; Chen W; Swanger SA; McDaniel MJ; Fan LZ; Hu C; Tankovic A; Kusumoto H; Kosobucki GJ; Schulien AJ; Su Z; Pecha J; Bhattacharya S; Petrovski S; Cohen AE; Aizenman E; Traynelis SF; Yuan H
    PLoS Genet; 2017 Jan; 13(1):e1006536. PubMed ID: 28095420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific pathogenic mutations in the M3 domain of the GluN1 subunit regulate the surface delivery and pharmacological sensitivity of NMDA receptors.
    Kolcheva M; Kortus S; Krausova BH; Barackova P; Misiachna A; Danacikova S; Kaniakova M; Hemelikova K; Hotovec M; Rehakova K; Horak M
    Neuropharmacology; 2021 May; 189():108528. PubMed ID: 33773999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The GluN2B-Glu413Gly NMDA receptor variant arising from a de novo GRIN2B mutation promotes ligand-unbinding and domain opening.
    Wells G; Yuan H; McDaniel MJ; Kusumoto H; Snyder JP; Liotta DC; Traynelis SF
    Proteins; 2018 Dec; 86(12):1265-1276. PubMed ID: 30168177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Rare Variant Identified Within the GluN2B C-Terminus in a Patient with Autism Affects NMDA Receptor Surface Expression and Spine Density.
    Liu S; Zhou L; Yuan H; Vieira M; Sanz-Clemente A; Badger JD; Lu W; Traynelis SF; Roche KW
    J Neurosci; 2017 Apr; 37(15):4093-4102. PubMed ID: 28283559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De novo GRIN variants in NMDA receptor M2 channel pore-forming loop are associated with neurological diseases.
    Li J; Zhang J; Tang W; Mizu RK; Kusumoto H; XiangWei W; Xu Y; Chen W; Amin JB; Hu C; Kannan V; Keller SR; Wilcox WR; Lemke JR; Myers SJ; Swanger SA; Wollmuth LP; Petrovski S; Traynelis SF; Yuan H
    Hum Mutat; 2019 Dec; 40(12):2393-2413. PubMed ID: 31429998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanistic Insight into NMDA Receptor Dysregulation by Rare Variants in the GluN2A and GluN2B Agonist Binding Domains.
    Swanger SA; Chen W; Wells G; Burger PB; Tankovic A; Bhattacharya S; Strong KL; Hu C; Kusumoto H; Zhang J; Adams DR; Millichap JJ; Petrovski S; Traynelis SF; Yuan H
    Am J Hum Genet; 2016 Dec; 99(6):1261-1280. PubMed ID: 27839871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface Expression, Function, and Pharmacology of Disease-Associated Mutations in the Membrane Domain of the Human GluN2B Subunit.
    Vyklicky V; Krausova B; Cerny J; Ladislav M; Smejkalova T; Kysilov B; Korinek M; Danacikova S; Horak M; Chodounska H; Kudova E; Vyklicky L
    Front Mol Neurosci; 2018; 11():110. PubMed ID: 29681796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synaptic NMDA receptors in basolateral amygdala principal neurons are triheteromeric proteins: physiological role of GluN2B subunits.
    Delaney AJ; Sedlak PL; Autuori E; Power JM; Sah P
    J Neurophysiol; 2013 Mar; 109(5):1391-402. PubMed ID: 23221411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trapping channel block of NMDA-activated responses by amantadine and memantine.
    Blanpied TA; Boeckman FA; Aizenman E; Johnson JW
    J Neurophysiol; 1997 Jan; 77(1):309-23. PubMed ID: 9120573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional Evaluation of a De Novo
    Chen W; Tankovic A; Burger PB; Kusumoto H; Traynelis SF; Yuan H
    Mol Pharmacol; 2017 Apr; 91(4):317-330. PubMed ID: 28126851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Binding Mode Reveals Two Distinct Classes of NMDA Receptor GluN2B-selective Antagonists.
    Stroebel D; Buhl DL; Knafels JD; Chanda PK; Green M; Sciabola S; Mony L; Paoletti P; Pandit J
    Mol Pharmacol; 2016 May; 89(5):541-51. PubMed ID: 26912815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synaptic Dysfunction by Mutations in
    Elmasri M; Lotti JS; Aziz W; Steele OG; Karachaliou E; Sakimura K; Hansen KB; Penn AC
    Brain Sci; 2022 Jun; 12(6):. PubMed ID: 35741674
    [No Abstract]   [Full Text] [Related]  

  • 16. Characterization of mice carrying a neurodevelopmental disease-associated GluN2B(L825V) variant.
    Candelas Serra M; Kuchtiak V; Kubik-Zahorodna A; Kysilov B; Fili K; Hrcka Krausova B; Abramova V; Dobrovolski M; Harant K; Bozikova P; Cerny J; Prochazka J; Kasparek P; Sedlacek R; Balik A; Smejkalova T; Vyklicky L
    J Neurosci; 2024 Jun; ():. PubMed ID: 38926089
    [No Abstract]   [Full Text] [Related]  

  • 17. Binding of ArgTX-636 in the NMDA receptor ion channel.
    Poulsen MH; Andersen J; Christensen R; Hansen KB; Traynelis SF; Strømgaard K; Kristensen AS
    J Mol Biol; 2015 Jan; 427(1):176-89. PubMed ID: 24862283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GRIN1 variants associated with neurodevelopmental disorders reveal channel gating pathomechanisms.
    Ragnarsson L; Zhang Z; Das SS; Tran P; Andersson Å; des Portes V; Desmettre Altuzarra C; Remerand G; Labalme A; Chatron N; Sanlaville D; Lesca G; Anggono V; Vetter I; Keramidas A
    Epilepsia; 2023 Dec; 64(12):3377-3388. PubMed ID: 37734923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered zinc sensitivity of NMDA receptors harboring clinically-relevant mutations.
    Serraz B; Grand T; Paoletti P
    Neuropharmacology; 2016 Oct; 109():196-204. PubMed ID: 27288002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NMDA receptor structures reveal subunit arrangement and pore architecture.
    Lee CH; Lü W; Michel JC; Goehring A; Du J; Song X; Gouaux E
    Nature; 2014 Jul; 511(7508):191-7. PubMed ID: 25008524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.